CUE - Cue Biopharma, Inc.
0.7661
0.047 6.174%
Share volume: 75,774
Last Updated: 04-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.14%
PREVIOUS CLOSE
CHG
CHG%
$0.72
0.05
0.07%
Summary score
39%
Profitability
25%
Dept financing
12%
Liquidity
75%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-23.07%
Return on assets
-17.04%
Return on sales
-5559.72%
Return on invested capital
96.44%
Total debt ratio
32.36%
Debt ratio change over timeo
-0.92%
Current Ratio
4.51%
Quick Ratio
5%
Cash Position Ratio
4.26%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-38.66%
Return on assets
-22.68%
Return on sales
-576.3%
Return on invested capital
165.98%
Total debt ratio
44.14%
Debt ratio change over timeo
-0.74%
Current Ratio
2.45%
Quick Ratio
2.74%
Cash Position Ratio
2.23%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-19.67%
Return on sales
-264.24%
Return on invested capital
0%
Total debt ratio
43.39%
Debt ratio change over time
-0.69%
Current Ratio
2.22%
Quick Ratio
0%
Cash Position Ratio
1.93%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-104.64%
Return on assets
-104.2%
Return on sales
1014.8%
Return on invested capital
7.65%
Total debt ratio
-91.83%
Debt ratio change over time
-0.92%
Current Ratio
-0.52%
Quick Ratio
-0.65%
Cash Position Ratio
-0.54%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CUE | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | -23.07% | 17.26% | 0% | 0% |
| Return on assets | -17.04% | 4.16% | 0% | 0% |
| Return on sales | -5559.72% | 27.72% | 0% | 0% |
| Return on invested capital | 96.44% | 9.99% | 0% | 0% |
| Profitability | 25% | 78% | 0% | 0% |
| Total debt ratio | 32.36% | 81.62% | 0% | 0% |
| Debt ratio change over time | -0.92% | -14.38% | 0% | 0% |
| Dept financing | 10% | 25% | 25% | 0% |
| Current Ratio | 2.45% | 1.16% | 0% | 0% |
| Quick Ratio | 2.74% | 0.89% | 0% | 0% |
| Cash Position Ratio | 2.23% | 0.12% | 0% | 0% |
| Liquididy | 75% | 12% | 0% | 0% |
| Short-term ratios | CUE | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | -38.66% | 18.92% | 0% | 0% |
| Return on assets | -22.68% | 3.96% | 0% | 0% |
| Return on sales | -576.3% | 27.19% | 0% | 0% |
| Return on invested capital | 165.98% | 15.53% | 0% | 0% |
| Profitability | 25% | 77% | 0% | 0% |
| Total debt ratio | 44.14% | 81.43% | 0% | 0% |
| Debt ratio change over time | -0.74% | -33.85% | 0% | 0% |
| Dept financing | 14% | 25% | 25% | 0% |
| Current Ratio | 2.45% | 1.16% | 0% | 0% |
| Quick Ratio | 2.74% | 0.89% | 0% | 0% |
| Cash Position Ratio | 2.23% | 0.12% | 0% | 0% |
| Liquididy | 75% | 21% | 0% | 0% |
